Skip to main content

CHARLES RIVER LABORATORIES INTERNATIONAL INC

For the period ended Dec 28, 2024. Filed Feb 19, 2025.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Feb 19, 2025

CRL$345.80-2.1%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Consolidated Statements of Comprehensive Income (Loss) for fiscal yearsand

Fiscal Year
202420232022
Net income$25,291$480,370$492,608
Other comprehensive income (loss):
Foreign currency translation adjustment(130,112)70,651(129,091)
Pension and other post-retirement benefit plans (Note 14):
Prior service cost and (losses) gains arising during the period(12,190)(5,376)24,471
Amortization of net loss, settlement losses, and prior service benefit included in total cost for pension and other post-retirement benefit plans1,5967363,337
Unrealized gains (losses) on hedging instruments(966)2,490(1,523)
Other comprehensive income (loss), before income taxes(141,672)68,501(102,806)
Less: Income tax (benefit) expense related to items of other comprehensive income (loss) (Note 12)(17,903)4,071(1,905)
Comprehensive income (loss), net of income taxes(98,478)544,800391,707
Less: Comprehensive income related to noncontrolling interests, net of income taxes2374,5462,798
Comprehensive income (loss) attributable to common shareholders, net of income taxes$(98,715)$540,254$388,909
See Notes to Consolidated Financial Statements.
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.